Sitagliptin 25mg Tablets

Sitagliptin 25mg is an oral DPP-4 inhibitor used for adults with type 2 diabetes for sitagliptin treatment. It helps raise active incretin hormone levels after meals, increasing glucose-dependent insulin release and reducing glucagon release when blood sugar is high. It is intended for type 2 diabetes, not type 1 diabetes or diabetic ketoacidosis.
Take Sitagliptin 25mg as prescribed, with or without food. Keep glucose monitoring and HbA1c follow-up. Dose should match kidney function and the wider diabetes plan.
Sitagliptin inhibits DPP-4, increasing active incretin hormones that improve glucose-dependent insulin release and reduce glucagon after meals.
Possible effects include headache, upper respiratory symptoms, stomach upset, and low blood sugar when combined with insulin or sulfonylureas. Serious concerns include pancreatitis, allergic swelling, severe joint pain, bullous pemphigoid, kidney problems, and heart-failure symptoms in at-risk patients.
Review kidney function/eGFR, pancreatitis history, heart failure, insulin or sulfonylurea use, allergy history, pregnancy, breastfeeding, glucose-monitoring plan, and symptoms of severe joint pain or blistering skin disease.
Type 2 diabetes mellitus in adults when sitagliptin therapy is prescribed.
Improves meal-related glucose control through incretin support with generally low hypoglycemia risk when not combined with insulin or sulfonylureas.
Sitagliptin 25mg is used to improve glucose control in adults with type 2 diabetes for sitagliptin treatment.
Sitagliptin dosing depends on kidney function, and lower doses may be needed with reduced eGFR.
Risk is usually lower alone, but it increases with insulin or sulfonylurea medicines.
Severe persistent upper abdominal pain, often with vomiting or back pain, needs urgent review.
No. It is intended for type 2 diabetes, not type 1 diabetes or diabetic ketoacidosis.
Sitagliptin, DPP-4 inhibitor, Type 2 diabetes medicine, Incretin hormone support, Kidney dose adjustment, Pancreatitis warning, AR: Sitagliptin أقراص, FR: Sitagliptin comprimé, PT: Sitagliptin comprimido, ES: Sitagliptin tableta, RU: Sitagliptin таблетки, ID: Sitagliptin, VI: Sitagliptin viên nén, MS: Sitagliptin, TL: Sitagliptin tableta, ZH-SG: Sitagliptin 片剂
International B2B Enquiry
Send a structured B2B enquiry for Sitagliptin 25mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Sitagliptin 25mg Tablets